China-Origin Drugmaker BeiGene to Rename Itself Amid Global Push Chinas leading innovative cancer drugmaker BeiGene Ltd. plans to change its name to BeOne Medicines as part of a rebranding to support its growth ambitions in markets including the US and Europe.

China-Origin Drugmaker BeiGene to Rename Itself Amid Global Push

About 67% of BGNE Old's investor base is looking to short. The analysis of current outlook of investing in BGNE Old suggests that many traders are alarmed regarding BGNE Old's prospects. The current market sentiment, together with BGNE Old's historical and current headlines, can help investors time the market. In addition, many technical investors use BGNE Old stock news signals to limit their universe of possible portfolio assets.
  
Chinas leading innovative cancer drugmaker BeiGene Ltd. plans to change its name to BeOne Medicines as part of a rebranding to support its growth ambitions in markets including the US and Europe.

Read at bnnbloomberg.ca
bloomberg News
  

BGNE Old Fundamental Analysis

We analyze BGNE Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BGNE Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BGNE Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

BGNE Old is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

BGNE Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BGNE Old stock to make a market-neutral strategy. Peer analysis of BGNE Old could also be used in its relative valuation, which is a method of valuing BGNE Old by comparing valuation metrics with similar companies.

Peers

BGNE Old Related Equities

IMABI Mab   11.70   
0%
100.0%
AKROAkero Therapeutics   2.94   
0%
25.0%
LEGNLegend Biotech   2.54   
0%
21.0%
APLSApellis Pharmaceuticals   2.07   
0%
17.0%
ASNDAscendis Pharma   1.23   
0%
10.0%
IMVTImmunovant   1.04   
0%
8.0%
ARWRArrowhead Pharmaceuticals   0.52   
0%
4.0%
INCYIncyte   0.42   
3.0%
0%
IONSIonis Pharmaceuticals   0.72   
6.0%
0%
BMRNBiomarin Pharmaceutical   0.80   
6.0%
0%
KRYSKrystal Biotech   1.10   
9.0%
0%
BPMCBlueprint Medicines   2.58   
22.0%
0%
PCVXVaxcyte   7.16   
61.0%
0%
TVTXTravere Therapeutics   10.59   
90.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in BGNE Stock

If you are still planning to invest in BGNE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BGNE Old's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data